0
Détail de la série
HIV and related infections in prisoners |
Documents disponibles dans cette série (6)
Ajouter le résultat dans votre panier Affiner la rechercheHIV and related infections in prisoners, 1. Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees / Kate Dolan (2016)
Titre de série : HIV and related infections in prisoners, 1 Titre : Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees Type de document : document électronique Auteurs : Kate Dolan, Auteur ; Andrea L. Wirtz, Auteur ; Babak Moazen, Auteur ; Martial Ndeffo-mbah, Auteur ; Alison Galvani, Auteur Editeur : Lancet Année de publication : 2016 Collection : The Lancet num. 388 (10049) Importance : p. 1089-1102 Présentation : ill. ; graph. Langues : Anglais (eng) Catégories : [PROMOSAN] étude:épidémiologie:établissement pénitentiaire
[TUBER] étude:épidémiologie:groupe à risque:sida
[TUBER] type de tuberculose:tuberculose-maladieIndex. décimale : TU 3.6.a. Prisons Résumé : The prison setting presents not only challenges, but also opportunities, for the prevention and treatment of HIV, viral hepatitis, and tuberculosis. We did a comprehensive literature search of data published between 2005 and 2015 to understand the global epidemiology of HIV, hepatitis C virus (HCV), hepatitis B virus (HBV), and tuberculosis in prisoners. We further modelled the contribution of imprisonment and the potential impact of prevention interventions on HIV transmission in this population. Of the estimated 10·2 million people incarcerated worldwide on any given day in 2014, we estimated that 3·8% have HIV (389 000 living with HIV), 15·1% have HCV (1 546 500), 4·8% have chronic HBV (491 500), and 2·8% have active tuberculosis (286 000). The few studies on incidence suggest that intraprison transmission is generally low, except for large-scale outbreaks. Our model indicates that decreasing the incarceration rate in people who inject drugs and providing opioid agonist therapy could reduce the burden of HIV in this population. The prevalence of HIV, HCV, HBV, and tuberculosis is higher in prison populations than in the general population, mainly because of the criminalisation of drug use and the detention of people who use drugs. The most effective way of controlling these infections in prisoners and the broader community is to reduce the incarceration of people who inject drugs. En ligne : https://doi.org/10.1016/S0140-6736(16)30466-4 Format de la ressource électronique : Article en ligne Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=10777 Aucun avis, veuillez vous identifier pour ajouter le vôtre !
Titre de série : HIV and related infections in prisoners, 2 Titre : Clinical care of incarcerated people with HIV, viral hepatitis, or tuberculosis Type de document : document électronique Auteurs : Josiah D. Rich, Auteur ; Curt G. Beckwith, Auteur ; Alexandria Macmadu, Auteur ; Brandon D.L. Marshall, Auteur ; Lauren Brinkley-Rubinstein, Auteur Editeur : Lancet Année de publication : 2016 Collection : The Lancet num. 388 (10049) Importance : p. 1103-1114 Présentation : ill. ; graph. Langues : Anglais (eng) Catégories : [PROMOSAN] étude:épidémiologie:établissement pénitentiaire
[TUBER] traitement:traitement curatif
[TUBER] type de tuberculose:tuberculose-maladieIndex. décimale : TU 8.5.4.a. Prisons Résumé : The burden of HIV/AIDS and other transmissible diseases is higher in prison and jail settings than in the non-incarcerated communities that surround them. In this comprehensive review, we discuss available literature on the topic of clinical management of people infected with HIV, hepatitis B and C viruses, and tuberculosis in incarcerated settings in addition to co-occurrence of one or more of these infections. Methods such as screening practices and provision of treatment during detainment periods are reviewed to identify the effect of community-based treatment when returning inmates into the general population. Where data are available, we describe differences in the provision of medical care in the prison and jail settings of low-income and middle-income countries compared with high-income countries. Structural barriers impede the optimal delivery of clinical care for prisoners, and substance use, mental illness, and infectious disease further complicate the delivery of care. For prison health care to reach the standards of community-based health care, political will and financial investment are required from governmental, medical, and humanitarian organisations worldwide. In this review, we highlight challenges, gaps in knowledge, and priorities for future research to improve health-care in institutions for prisoners. En ligne : https://doi.org/10.1016/S0140-6736(16)30379-8 Format de la ressource électronique : Article en ligne Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=10778 Aucun avis, veuillez vous identifier pour ajouter le vôtre !
Titre de série : HIV and related infections in prisoners, 3 Titre : Clinical care of Prevention of transmission of HIV, hepatitis B virus, hepatitis C virus, and tuberculosis in prisonerspeople with HIV, viral hepatitis, or tuberculosis Type de document : document électronique Auteurs : Adeeba Kamarulzaman, Auteur ; Stewart E. Reid, Auteur ; Amee Schwitters, Auteur ; Lucas Wiessing, Auteur ; Nabila El-Bassel, Auteur Editeur : Lancet Année de publication : 2016 Collection : The Lancet num. 388 (10049) Importance : p. 1115-1126 Présentation : ill. ; tab. Langues : Anglais (eng) Catégories : [PROMOSAN] étude:épidémiologie:établissement pénitentiaire
[TUBER] étude:statistique:prévalence
[TUBER] prévention
[TUBER] type de tuberculose:tuberculose-maladieIndex. décimale : TU 3.6.a. Prisons Résumé : The prevalence of HIV, hepatitis B virus, hepatitis C virus, and tuberculosis are higher in prisons than in the general population in most countries worldwide. Prisons have emerged as a risk environment for these infections to be further concentrated, amplified, and then transmitted to the community after prisoners are released. In the absence of alternatives to incarceration, prisons and detention facilities could be leveraged to promote primary and secondary prevention strategies for these infections to improve prisoners health and reduce risk throughout incarceration and on release. Effective treatment of opioid use disorders with opioid agonist therapies (eg, methadone and buprenorphine) prevents blood-borne infections via reductions in injection in prison and after release. However, large gaps exist in the implementation of these strategies across all regions. Collaboration between the criminal justice and public health systems will be required for successful implementation of these strategies.
En ligne : https://doi.org/10.1016/S0140-6736(16)30769-3 Format de la ressource électronique : Article en ligne Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=10779 Aucun avis, veuillez vous identifier pour ajouter le vôtre !
Titre de série : HIV and related infections in prisoners, 4 Titre : HIV, prisoners, and human rights Type de document : document électronique Auteurs : Leonard S. Rubenstein, Auteur ; Joseph D. Amon, Auteur ; Megan McLemore, Auteur ; Patrick Eba, Auteur ; Kate Dolan, Auteur Editeur : Lancet Année de publication : 2016 Collection : The Lancet num. 388 (10050) Importance : p. 1202-1214 Présentation : tab. Langues : Anglais (eng) Catégories : [PROMOSAN] étude:épidémiologie:établissement pénitentiaire
[TUBER] aspect socio-économique
[TUBER] étude:épidémiologie:groupe à risque:sidaMots-clés : discrimination législation Index. décimale : TU 3.6.a. Prisons Résumé : Worldwide, a disproportionate burden of HIV, tuberculosis, and hepatitis is present among current and former prisoners. This problem results from laws, policies, and policing practices that unjustly and discriminatorily detain individuals and fail to ensure continuity of prevention, care, and treatment upon detention, throughout imprisonment, and upon release. These government actions, and the failure to ensure humane prison conditions, constitute violations of human rights to be free of discrimination and cruel and inhuman treatment, to due process of law, and to health. Although interventions to prevent and treat HIV, tuberculosis, hepatitis, and drug dependence have proven successful in prisons and are required by international law, they commonly are not available. Prison health services are often not governed by ministries responsible for national public health programmes, and prison officials are often unwilling to implement effective prevention measures such as needle exchange, condom distribution, and opioid substitution therapy in custodial settings, often based on mistaken ideas about their incompatibility with prison security. In nearly all countries, prisoners face stigma and social marginalisation upon release and frequently are unable to access health and social support services. Reforms in criminal law, policing practices, and justice systems to reduce imprisonment, reforms in the organisation and management of prisons and their health services, and greater investment of resources are needed.
En ligne : https://doi.org/10.1016/S0140-6736(16)30663-8 Format de la ressource électronique : Article en ligne Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=10780 Aucun avis, veuillez vous identifier pour ajouter le vôtre !
Titre de série : HIV and related infections in prisoners, 5 Titre : HIV and tuberculosis in prisons in sub-Saharan Africa Type de document : document électronique Auteurs : Lilanganee Telisinghe, Auteur ; Salome Charalambous, Auteur ; Stephanie M. Topp, Auteur ; Michael E. Herce, Auteur ; Christopher J. Hoffmann, Auteur Editeur : Lancet Année de publication : 2016 Collection : The Lancet num. 388 (10050) Importance : p. 1215-1227 Présentation : ill. ; graph. Langues : Anglais (eng) Catégories : [DIVERS] géographie:Afrique:Afrique subsaharienne
[PROMOSAN] étude:épidémiologie:établissement pénitentiaire
[TUBER] étude:épidémiologie:groupe à risque:sida
[TUBER] type de tuberculose:tuberculose-maladieIndex. décimale : TU 3.6.a. Prisons Résumé : Given the dual epidemics of HIV and tuberculosis in sub-Saharan Africa and evidence suggesting a disproportionate burden of these diseases among detainees in the region, we aimed to investigate the epidemiology of HIV and tuberculosis in prison populations, describe services available and challenges to service delivery, and identify priority areas for programmatically relevant research in sub-Saharan African prisons. To this end, we reviewed literature on HIV and tuberculosis in sub-Saharan African prisons published between 2011 and 2015, and identified data from only 24 of the 49 countries in the region. Where data were available, they were frequently of poor quality and rarely nationally representative. Prevalence of HIV infection ranged from 2·3% to 34·9%, and of tuberculosis from 0·4 to 16·3%; detainees nearly always had a higher prevalence of both diseases than did the non-incarcerated population in the same country. We identified barriers to prevention, treatment, and care services in published work and through five case studies of prison health policies and services in Zambia, South Africa, Malawi, Nigeria, and Benin. These barriers included severe financial and human-resource limitations and fragmented referral systems that prevent continuity of care when detainees cycle into and out of prison, or move between prisons. These challenges are set against the backdrop of weak health and criminal-justice systems, high rates of pre-trial detention, and overcrowding. A few examples of promising practices exist, including routine voluntary testing for HIV and screening for tuberculosis upon entry to South African and the largest Zambian prisons, reforms to pre-trial detention in South Africa, integration of mental health services into a health package in selected Malawian prisons, and task sharing to include detainees in care provision through peer-educator programmes in Rwanda, Zimbabwe, Zambia, and South Africa. However, substantial additional investments are required throughout sub-Saharan Africa to develop country-level policy guidance, build human-resource capacity, and strengthen prison health systems to ensure universal access to HIV and tuberculsosis prevention, treatment, and care of a standard that meets international goals and human rights obligations. En ligne : https://doi.org/10.1016/S0140-6736(16)30578-5 Format de la ressource électronique : Article en ligne Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=10781 Aucun avis, veuillez vous identifier pour ajouter le vôtre !
Titre de série : HIV and related infections in prisoners, 6 Titre : The perfect storm: incarceration and the high-risk environment perpetuating transmission of HIV, hepatitis C virus, and tuberculosis in Eastern Europe and Central Asia Type de document : document électronique Auteurs : Frederick L. Altice, Auteur ; Lyuba Azbel, Auteur ; Jack Stone, Auteur ; Ellen Brooks-Pollock, Auteur ; Pavlo Smyrnov, Auteur Editeur : Lancet Année de publication : 2016 Collection : The Lancet num. 388 (10050) Importance : p. 1228-1248 Présentation : ill. ; graph. ; tab. Langues : Anglais (eng) Catégories : [DIVERS] géographie:Asie:Russie
[DIVERS] géographie:Europe:Europe centrale et orientale
[PROMOSAN] étude:épidémiologie:établissement pénitentiaire
[TUBER] étude:épidémiologie:groupe à risque:sida
[TUBER] prévention
[TUBER] type de tuberculose:tuberculose-maladieIndex. décimale : TU 3.6.a. Prisons Résumé : Despite global reductions in HIV incidence and mortality, the 15 UNAIDS-designated countries of Eastern Europe and Central Asia (EECA) that gained independence from the Soviet Union in 1991 constitute the only region where both continue to rise. HIV transmission in EECA is fuelled primarily by injection of opioids, with harsh criminalisation of drug use that has resulted in extraordinarily high levels of incarceration. Consequently, people who inject drugs, including those with HIV, hepatitis C virus, and tuberculosis, are concentrated within prisons. Evidence-based primary and secondary prevention of HIV using opioid agonist therapies such as methadone and buprenorphine is available in prisons in only a handful of EECA countries (methadone or buprenorphine in five countries and needle and syringe programmes in three countries), with none of them meeting recommended coverage levels. Similarly, antiretroviral therapy coverage, especially among people who inject drugs, is markedly under-scaled. Russia completely bans opioid agonist therapies and does not support needle and syringe programmes—with neither available in prisons—despite the country's high incarceration rate and having the largest burden of people with HIV who inject drugs in the region. Mathematical modelling for Ukraine suggests that high levels of incarceration in EECA countries facilitate HIV transmission among people who inject drugs, with 28–55% of all new HIV infections over the next 15 years predicted to be attributable to heightened HIV transmission risk among currently or previously incarcerated people who inject drugs. Scaling up of opioid agonist therapies within prisons and maintaining treatment after release would yield the greatest HIV transmission reduction in people who inject drugs. Additional analyses also suggest that at least 6% of all incident tuberculosis cases, and 75% of incident tuberculosis cases in people who inject drugs are due to incarceration. Interventions that reduce incarceration itself and effectively intervene with prisoners to screen, diagnose, and treat addiction and HIV, hepatitis C virus, and tuberculosis are urgently needed to stem the multiple overlapping epidemics concentrated in prisons.
En ligne : https://doi.org/10.1016/S0140-6736(16)30856-X Format de la ressource électronique : Article en ligne Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=10782 Aucun avis, veuillez vous identifier pour ajouter le vôtre !
